2026-01-19 - Analysis Report
## Overview of Align Technology - 의료 기기 및 진단 장비 글로벌 리더

### Comparison to S&P 500

- Cumulative return of review stock (ALGN): -47.54%
- Cumulative return of comparison stock (VOO): 82.54%
- Divergence: N/A
- Rate (ALGN): N/A
- Rate_vs (VOO): 82.54%

The review stock and S&P 500 have shown significant divergence in their cumulative returns.

### Alpha, Beta analysis

| Year | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | -3.0% | 19.6% | -3.0% | 1.5 | 15.2B |
| 2017-2019 | -1.0% | 40.2% | -10.0% | 1.6 | 20.2B |
| 2018-2020 | 31.0% | 40.2% | 10.0% | 1.5 | 38.7B |
| 2019-2021 | 32.0% | 40.2% | -5.0% | 1.5 | 47.6B |
| 2020-2022 | -42.0% | 62.9% | -52.0% | 1.5 | 15.3B |
| 2021-2023 | -59.0% | 62.9% | -75.0% | 1.7 | 19.9B |
| 2022-2024 | -58.0% | 54.5% | -84.0% | 1.7 | 15.1B |
| 2023-2025 | -34.0% | 50.8% | -83.0% | 1.5 | 11.3B |

### Recent Stock Price Fluctuations

- Close: $171.49
- Last-market: Up 0.01%
- 5-day moving average (SMA): $170.88
- 20-day SMA: $163.59
- 60-day SMA: $150.99

The current price is just above the 5-day SMA, showing some stability, while it continues to be above the 20-day and 60-day SMAs.

### RSI, PPO index indicators and Delta_Previous_Relative_Divergence, Expected_Return

- Market Risk Indicator (MRI): 0.80 (Recommended for Medium Investment)
- RSI: 74.10
- PPO: 0.16
- Recent (20-day) relative divergence change: 0 (flat)
- 7-day Rank change: 0 (flat)
- 7-day Dynamic Expected Return change: 0.0 (flat)
- Expected Return (%): N/A

The RSI is over 70, indicating an overbought situation, while the PPO is below 1, which may be a buy signal.

### Recent News & Significant Events

- Assessing Align Technology (ALGN) Valuation After Recent Share Price Rebound And Modest Discount Signals - simplywall.st
- 3 Reasons to Avoid ALGN and 1 Stock to Buy Instead - Yahoo Finance
- 30 Canadian kids get Invisalign care through new Smiles4Canada effort - Stock Titan
- Why Align Technology Stock Popped Today - The Motley Fool
- Align Technology Stock Forecast: Where Analysts See the Stock by 2027 - TIKR.com
- ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash - Zacks Investment Research

### Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 15
- Target Price (avg/high/low): 180.47 / 220.00 / 150.00

### Recent Earnings Analysis

| Date | EPS | Revenue |
| ---:|----:|--------:|
| 2025-11-05 | 0.78 | 1.00 B$ |
| 2025-08-06 | 1.72 | 1.01 B$ |
| 2025-05-08 | 1.27 | 0.98 B$ |
| 2024-11-05 | 1.55 | 0.98 B$ |

The revenue has shown stability, while the EPS has fluctuated.

### Financial Information - Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

The revenue has shown stability, and the profit margin has been consistently high.

### Financial Information - Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The equity has shown some stability, while the ROE has fluctuated.

### Comprehensive Analysis (Summary of previous items)

- The review stock and S&P 500 have shown significant divergence in their cumulative returns.
- The review stock has shown fluctuating performance in the Alpha, Beta analysis with negative CAGR in most years.
- The current price is stable with respect to the moving averages.
- The RSI is over 70 indicating an overbought situation.
- The Analyst Consensus is a Buy with a target price of 180.47.
- The revenue has shown stability in recent quarters, but the EPS has fluctuated.
- The profit margin remains consistently high, but the ROE has fluctuated.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.